RxDoctor Payments Data

Tyler Johnson, PA

Medical · Waconia, MNNPI 1003362914

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $24,300 of the $28,179 with a category attached, or 86.2%. Lilly USA, LLC accounts for 95.4% of it on its own, with 9 other manufacturers making up the rest. Among medical clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$28,179in general payments, 2019–2025

Across 82 payments — averaging $343.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$27K
  • Johnson & Johnson$1K
  • Regeneron Healthcare Solutions, Inc.$75
  • Galderma Laboratories, L.p.$34
  • Organon$17
  • E.r. Squibb & Sons, L.L.C.$16
  • plus $57 from 4 others

What the payments were for

  • Consulting fees$1,0634%
  • Speaking & faculty fees$24,30086%
  • Travel & lodging$1,7086%
  • Food & beverage$1,1084%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$28,179 in reported general payments places this provider in the 95th percentile of 202 medical providers in Minnesota.

See all medical providers in Minnesota

Medicare billing

Part B allowed, 2024
$58,462
Medicare patients
427
Services billed
1,693

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cosentyx Sensoready (2 Pens)Secukinumab20$146,638
Dupixent PenDupilumab35$138,312
OtezlaApremilast13$75,845
Calcipotriene25$5,848
Tacrolimus23$2,378
Doxycycline Hyclate73$1,909
Ketoconazole114$1,679
Fluorouracil22$1,559
Clobetasol Propionate43$1,392
Metronidazole31$1,378
Clindamycin Phosphate34$1,374
Betamethasone Dipropionate23$1,050
Triamcinolone Acetonide81$970
Fluocinonide31$962
Doxycycline Monohydrate18$784

Paid to pharmacies, not to this prescriber.

Other medical in Waconia

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →